Polen Capital Management »

Alnylam Pharmaceuticals shares owned by Polen Capital Management

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Polen Capital Management from 13F filings

Historical chart of Polen Capital Management investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Polen Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Polen Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $316k 693 456.00

More positions owned by Polen Capital Management

Oracle Corporation (ORCL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Shopify Cl A Sub Vtg Shs (SHOP)
Mastercard Incorporated Cl A (MA)
Visa Com Cl A (V)
Broadcom (AVGO)
Eli Lilly & Co. (LLY)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl C (GOOG)
Zoetis Cl A (ZTS)
Servicenow (NOW)
Abbott Laboratories (ABT)
Msci (MSCI)
Aon Shs Cl A (AON)

View all positions for Polen Capital Management

Top funds holding Alnylam Pharmaceuticals

FMR
Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
Jpmorgan Chase & Co
Groupama Asset Managment
State Street Corporation
Baillie Gifford & Co
Geode Capital Management
Dodge & Cox
T. Rowe Price Investment Management
Orbis Allan Gray
Wellington Management Company
Susquehanna International

View all funds holding Alnylam Pharmaceuticals